The Genotype Advisory (TGA) connects companies with matching genotypes, either investors or licensees by way of the TGA online platform. Worldwide, TGA’s platform is unique - there is no one like us.
At TGA, we bridge the gap between innovation and continued growth. We serve as a trusted partner for European Life Sciences companies with a view to connect them with investors, licensees or licensors. We specialise exclusively in the Life Sciences sector , i.e. pharma, biotech, and medtech.
Due to the geopolitical tensions, US and EU companies are increasingly in-licensing early-stage Chinese assets (regularly ex-China rights), particularly in oncology, immuno-oncology and cell/gene therapy. Reciprocally however, Chinese companies also wish to in-license from Europe. TGA connects your company to licensors and licensees in China.
Just tell us your needs.